1. Interleukin 9 serum level and single nucleotide polymorphism in patients with asthma.
- Author
-
Mahdaviani SA, Eskian M, Khorasanizadeh M, Bashardoost B, Tashayoie Nejad S, Jamaati HR, Rezaei A, Sadr M, Aryan Z, and Rezaei N
- Subjects
- Adolescent, Adult, Case-Control Studies, Humans, Middle Aged, Respiratory Function Tests, Young Adult, Asthma genetics, Interleukin-9 blood, Polymorphism, Single Nucleotide
- Abstract
Background: Asthma is a chronic inflammatory disease of airways which accounts for a huge economic, morbidity and mortality burden. There are different cytokines that contribute to asthma pathophysiology. Learning about these cytokines leads to attaining novel anti-inflammatory treatments for asthma control., Objectives: The objective of this study is to investigate the association between interleukin-9 serum level and gene polymorphism with asthma susceptibility., Methods: This was a case-control study of 70 asthmatic patients and 77 healthy control adults aged 18-60. Asthma diagnosis and severity were based on physician diagnosis, pulmonary function test (PFT) and 2016 guild line of Global Initiative for Asthma (GINA). Interleukin 9(IL -9) serum level was measured using sandwich enzyme linked immunosorbent assay. IL9 promoter single nucleotide polymorphism (SNP) (rs2069882) was also assessed using Real-Time PCR System., Results: There was no significant association between IL-9 SNP polymorphism and asthma. IL-9 serum level was significantly associated with asthma susceptibility (p value= 0.016) and absolute eosinophil count (AEC) (P value=0.033) however its corelation with atopic asthma type, asthma sivierity and Immunoglubin E serum level were not statistically significant., Conclusion: Although there was no association between IL-9 SNP and asthma, but IL-9 serum level was significantly correlated with asthma susceptibility and AEC.
- Published
- 2021
- Full Text
- View/download PDF